Treatment of hypermyoglobinemia after CRS plus HIPEC for patients with peritoneal carcinomatosis: A retrospective comparative study

被引:7
|
作者
Liu, Gang [1 ]
Ji, Zhong-He [1 ]
Yu, Yang [1 ]
Li, Xin-Bao [1 ]
Zhang, Yan-Bin [1 ]
Peng, Kai-Wen [1 ]
Li, Yan [1 ]
机构
[1] Capital Med Univ, Beijing Shijitan Hosp, Dept Peritoneal Canc Surg, 10 Tieyi Rd,Yangfangdian St, Beijing 100038, Peoples R China
关键词
cytoreductive surgery; hypermyoglobinemia; hyperthermic intraperitoneal chemotherapy; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; EPITHELIAL OVARIAN-CANCER; ACUTE KIDNEY INJURY; CYTOREDUCTIVE SURGERY; PSEUDOMYXOMA PERITONEI; COLORECTAL-CANCER; CHINESE CENTER; MYOGLOBIN; TRIAL;
D O I
10.1097/MD.0000000000008573
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This retrospective comparative study aims to explore the time courses of serum myoglobin (Mb) changes, and summarize our experience in treating patients with hypermyoglobinemia after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).This study covered 60 patients with peritoneal carcinomatosis treated with CRS + HIPEC as the study group, and another 25 cancer patients treated with conventional extensive surgery without HIPEC as the control group from February to October 2016. In the study group, patients with postoperative hypermyoglobinemia were on a comprehensive treatment regimen consisting intravenous injection of sodium bicarbonate solution according to the Mb level. In the control group, patients were recorded and treated with the same regimen except for special sodium bicarbonate solution. The preoperative and postoperative serum Mb, blood urine nitrogen (BUN), and creatinine (Cr) levels were evaluated.There were no significantly difference between the 2 groups in serum Mb, BUN, and Cr levels before surgery. Postoperative serum Mb levels were elevated in both groups and significantly higher on postoperative 0 to 2 days (P<.05) in the study group than the control group. The peak value of serum Mb levels (426.65108.386 g/L) occurred on the surgery day. The serum Mb change rate was much bigger in the study group than the control group. Serum BUN levels in both groups revealed a slow increase during the early postoperative period and were significantly lower in the study group than the control group on days 1 and 2. The serum Cr levels were similar and stable between the 2 groups after surgery. The serum Cr change rates changed synchronously with same tendency in both groups, and on postoperative day 1 the increase rate was bigger in the control group than the study group.Hypermyoglobinemia is a common and prominent lab abnormality after CRS + HIPEC, and serum Mb levels could be an early and sensitive indicator for dramatic disturbances in the internal milieu after CRS + HIPEC. Adequate treatment with sodium bicarbonate could accelerate the reduction in serum Mb levels and reduce the risk for major organ damages.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with peritoneal carcinomatosis (PC) of appendiceal origin (AO).
    Sardi, Armando
    Milovanov, Vladimir
    Sittig, Michelle
    Gushchin, Vadim
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [32] Predictors of complications after cytoreductive surgery associated with HIPEC in the treatment of peritoneal carcinomatosis.
    Ferreira, Fabio Oliveira
    Aguiar, Samuel
    Lima, Alessandro
    Monteiro Santos, Erika Maria
    Nakagawa, Wilson Toshihiko
    Bressan, Alexsander Kurowa
    Mello, Celso Lopes
    Lopes, Ademar
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [33] Does Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) Reduce Persistent Opioid Use in Patients with Peritoneal Carcinomatosis?
    Pu, T.
    Share, M.
    Russell, G.
    Erali, R. A.
    Madeka, I.
    Shen, P.
    Votanopoulos, K. I.
    Levine, E. A.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S119 - S119
  • [34] Early Postoperative Intraperitoneal Chemotherapy (EPIC) after Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Treatment of Peritoneal Carcinomatosis Results in Greater Morbidity
    Tan, G. H.
    Chia, C.
    Ong, W.
    Soo, K.
    Teo, M.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S158 - S158
  • [35] CYTOREDUCTIVE SURGERY AND HIPEC FOR THE TREATMENT OF ENDOMETRIAL CANCER WITH PERITONEAL CARCINOMATOSIS
    Halkia, E.
    Kourakos, A.
    Metaxas, T.
    Kotsopoulos, P.
    Vaikos, D.
    Kalakonas, A.
    Papadopoulos, A.
    Christakis, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1071 - 1071
  • [36] Predictors of Severe Morbidity After Cytoreductive Surgery and HIPEC in Patients with Colorectal Peritoneal Carcinomatosis
    Simkens, G.
    van Oudheusden, T.
    Luyer, M.
    Nienhuijs, S.
    Nieuwenhuijzen, G.
    Rutten, H.
    de Hingh, I.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S79 - S79
  • [37] Hyperthermic intraperitoneal chemotherapy (HIPEC). Mechanisms of action and the role of HIPEC in the treatment of peritoneal carcinomatosis
    Bartos, Adrian
    Bartos, Dana
    Herdean, Andrei
    Szabo, Bianca
    Militaru, Claudia
    Raluca, Stoian
    Calin, Mitre
    Iancu, Cornel
    Breazu, Caius
    ANNALI ITALIANI DI CHIRURGIA, 2018, 89 (06) : 513 - 527
  • [38] Retrospective Analysis of Patients with Signet Ring Subtype of Colorectal Cancer with Peritoneal Metastasis Treated with CRS & HIPEC
    Prabhu, Aruna
    Brandl, Andreas
    Wakama, Satoshi
    Sako, Shouzou
    Ishibashi, Haruaki
    Mizumoto, Akiyoshi
    Takao, Nobuyuki
    Noguchi, Kousuke
    Motoi, Shunsuke
    Ichinose, Masumi
    Liu, Yang
    Yonemura, Yutaka
    CANCERS, 2020, 12 (09) : 1 - 12
  • [39] Role of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) in the Treatment of Peritoneal Carcinomatosis from Small Bowel Adenocarcinoma: A Systematic Review
    Fernando, Deemantha
    SenthilKumar, Gopika
    Clarke, Callisia
    Gamblin, Thomas Clark
    Christians, Kathleen
    Mogal, Harveshp
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2020, 231 (04) : E212 - E213
  • [40] Cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy (HIPEC) in the management of peritoneal carcinomatosis in a community setting.
    Arregui, Maurice
    Singh, Kirpal
    Gupta, Niraj K.
    Arevalo, Gabriel
    Fuentes, Rocio
    Maciel, Victor
    Martinez, Brandon Keith
    Mathavan, Vinay
    MaCammack, Erin
    Aziz, Tariq
    Callin, Marius
    Davis, Chad
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)